DRUG · COUNSELLING NOTES
Tebentafusp
KIMMTRAK
Updated
New prescription
indication: _____. weekly IV; first 3 doses monitored in hospital; warned on allergies; serious/common AEs: cytokine release syndrome, rash, itching, fatigue; non-pharm: hydration, rest, report fever
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; weekly IV; first 3 doses monitored in hospital; warned on allergies; serious/common AEs: cytokine release syndrome, rash, itching, fatigue; non-pharm: hydration, rest, report fever